A
Algernon Pharmaceuticals Inc
CNSX:AGN
Algernon Pharmaceuticals Inc
CNSX:AGN
Price:
0.055
CAD
10%
Market Closed
Market Cap:
CA$2.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Algernon Pharmaceuticals Inc
CNSX:AGN
|
CA |
|
Agree Realty Corp
NYSE:ADC
|
US |
|
Goodbaby International Holdings Ltd
HKEX:1086
|
CN |
|
E
|
Euroconsultants SA
ATHEX:EUROC
|
GR |
|
Donnelley Financial Solutions Inc
NYSE:DFIN
|
US |
|
Sunhydrogen Inc
OTC:HYSR
|
US |
|
C
|
Colruyt Group NV
XBRU:COLR
|
BE |
|
Chainqui Construction Development Co Ltd
TWSE:2509
|
TW |
|
Woojin Inc
KRX:105840
|
KR |
|
Wellnex Life Ltd
ASX:WNX
|
AU |
|
Abercrombie & Fitch Co
NYSE:ANF
|
US |
|
C
|
Chongqing Jianshe Vehicle System Co Ltd
SZSE:200054
|
CN |
|
R
|
Refinverse Group Inc
TSE:7375
|
JP |
|
Sartorius AG
OTC:SARTF
|
DE |
|
Brookfield Infrastructure Corp
NYSE:BIPC
|
US |
|
O-I Glass Inc
NYSE:OI
|
US |
|
L
|
Linkers Industries Ltd
NASDAQ:LNKS
|
MY |
|
H
|
Hubei Huaqiang High-Tech Co Ltd
SSE:688151
|
CN |
|
S
|
Solize Corp
TSE:5871
|
JP |
|
S
|
Singapore Airlines Ltd
XHAM:SIA1
|
SG |
|
Cofidur SA
PAR:ALCOF
|
FR |
|
Renaissance United Ltd
SGX:I11
|
SG |
|
P
|
Pearl Holdings Acquisition Corp
NASDAQ:PRLH
|
US |
|
PCI Technology Group Co Ltd
SSE:600728
|
CN |
Income Statement
Earnings Waterfall
Algernon Pharmaceuticals Inc
Algernon Pharmaceuticals Inc
Income Statement
Algernon Pharmaceuticals Inc
Algernon Pharmaceuticals Inc
Currency: CAD
| Aug-2017 | Nov-2017 | Feb-2018 | May-2018 | Aug-2018 | Nov-2018 | Feb-2019 | May-2019 | Aug-2019 | Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(6)
|
(9)
|
(12)
|
(13)
|
(10)
|
(8)
|
(6)
|
(5)
|
(4)
|
(6)
|
(7)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(3)
|
(2)
|
(1)
|
0
|
(2)
|
(2)
|
(2)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(6)
|
(7)
|
(7)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(2)
|
(3)
|
(5)
|
(6)
|
(6)
|
(5)
|
(3)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(1)
N/A
|
(2)
-10%
|
(1)
+11%
|
(1)
+26%
|
(1)
+10%
|
(1)
-33%
|
(2)
-23%
|
(2)
-9%
|
(2)
-14%
|
(2)
+13%
|
(2)
-21%
|
(6)
-211%
|
(9)
-39%
|
(12)
-37%
|
(13)
-13%
|
(10)
+23%
|
(8)
+22%
|
(6)
+28%
|
(5)
+9%
|
(4)
+17%
|
(6)
-37%
|
(7)
-12%
|
(6)
+9%
|
(6)
-5%
|
(5)
+19%
|
(5)
-3%
|
(5)
+4%
|
(3)
+43%
|
(2)
+19%
|
(1)
+75%
|
0
N/A
|
(2)
N/A
|
(2)
+2%
|
(2)
-13%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
2
|
0
|
0
|
(0)
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(2)
N/A
|
(2)
+17%
|
(1)
+10%
|
(1)
+26%
|
(1)
+10%
|
(1)
-33%
|
(2)
-23%
|
(2)
-9%
|
(2)
-14%
|
(2)
+17%
|
(2)
-22%
|
(6)
-213%
|
(9)
-43%
|
(12)
-38%
|
(13)
-14%
|
(10)
+22%
|
(8)
+26%
|
(6)
+29%
|
(5)
+10%
|
(4)
+18%
|
(6)
-48%
|
(7)
-11%
|
(6)
+9%
|
(6)
-5%
|
(7)
-5%
|
(5)
+20%
|
(5)
+4%
|
(3)
+50%
|
(1)
+81%
|
(0)
+28%
|
0
N/A
|
(2)
N/A
|
(2)
+2%
|
(2)
-13%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Income from Continuing Operations |
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(6)
|
(9)
|
(12)
|
(13)
|
(10)
|
(8)
|
(6)
|
(5)
|
(4)
|
(6)
|
(7)
|
(6)
|
(6)
|
(7)
|
(5)
|
(5)
|
(3)
|
(1)
|
(0)
|
0
|
(2)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(2)
N/A
|
(2)
+17%
|
(1)
+10%
|
(1)
+26%
|
(1)
+10%
|
(1)
-33%
|
(2)
-23%
|
(2)
-9%
|
(2)
-14%
|
(2)
+17%
|
(2)
-22%
|
(6)
-213%
|
(9)
-43%
|
(12)
-38%
|
(13)
-14%
|
(10)
+22%
|
(8)
+26%
|
(6)
+29%
|
(5)
+10%
|
(4)
+18%
|
(6)
-48%
|
(7)
-11%
|
(6)
+9%
|
(6)
-5%
|
(7)
-5%
|
(5)
+20%
|
(5)
+4%
|
(3)
+50%
|
(1)
+81%
|
(0)
+28%
|
0
N/A
|
(2)
N/A
|
(2)
+2%
|
(2)
-13%
|
|
| EPS (Diluted) |
-1.84
N/A
|
-0.06
+97%
|
-0.06
N/A
|
-0.04
+33%
|
-1.66
-4 050%
|
-0.04
+98%
|
-0.04
N/A
|
-0.04
N/A
|
-1.06
-2 550%
|
-0.03
+97%
|
-0.03
N/A
|
-5.75
-19 067%
|
-2.42
+58%
|
-8.46
-250%
|
-9.28
-10%
|
-6.3
+32%
|
-1.24
+80%
|
-0.82
+34%
|
-0.73
+11%
|
-0.6
+18%
|
-0.87
-45%
|
-0.7
+20%
|
-0.63
+10%
|
-0.58
+8%
|
-0.45
+22%
|
-0.34
+24%
|
-0.26
+24%
|
-0.11
+58%
|
-0.03
+73%
|
-0.02
+33%
|
0.02
N/A
|
-0.07
N/A
|
-0.06
+14%
|
-0.06
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
